Aadi Bioscience Inc
(NAS:AADI)
$
1.405
0.005 (0.36%)
Market Cap: 34.50 Mil
Enterprise Value: -52.73 Mil
PE Ratio: 0
PB Ratio: 0.38
GF Score: 30/100 - Q1 2024 Aadi Bioscience Inc Earnings Call TranscriptMay 08, 2024$1.84 (-12.80%)Earnings
- Q4 2023 Aadi Bioscience Inc Earnings Call TranscriptMar 13, 2024$2.16 (+11.34%)Earnings
- Aadi Bioscience Inc Investor Conferece Call TranscriptDec 14, 2023
- Aadi Bioscience Inc at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Aadi Bioscience Inc Earnings Call TranscriptNov 08, 2023$4.65 (-3.53%)Earnings
- Aadi Bioscience Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Aadi Bioscience Inc Earnings Call TranscriptAug 09, 2023$5.44 (-6.85%)Earnings
- Aadi Bioscience Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Aadi Bioscience Inc at TD Cowen Oncology Innovation Summit (Virtual) TranscriptMay 30, 2023
- Q1 2023 Aadi Bioscience Inc Earnings Call TranscriptMay 10, 2023$7.08 (-16.61%)Earnings
- Q4 2022 Aadi Bioscience Inc Earnings Call TranscriptMar 28, 2023$6.85 (-5.52%)Earnings
- Q3 2022 Aadi Bioscience Inc Earnings Call TranscriptNov 09, 2022$13.41 (+2.84%)Earnings
- Aadi Bioscience Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Aadi Bioscience Inc Earnings Call TranscriptAug 10, 2022$13.88 (-1.49%)Earnings
- Q1 2022 Aadi Bioscience Inc Earnings Call TranscriptMay 12, 2022$12.65 (+9.33%)Earnings
- Aadi Bioscience Inc FYARRO Corporate Call TranscriptNov 23, 2021
- Aadi Bioscience Inc at H C Wainwright Precision Oncology Conference (Virtual) TranscriptOct 20, 2021
- Q3 2020 Aerpio Pharmaceuticals Inc Earnings Call TranscriptNov 10, 2020Earnings
- Q2 2020 Aerpio Pharmaceuticals Inc Earnings Call TranscriptAug 12, 2020Earnings
- Aerpio Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 24, 2020
- Aerpio Pharmaceuticals, Inc. - Special Call TranscriptJun 12, 2020
- Q4 2019 Aerpio Pharmaceuticals Inc Earnings Call TranscriptMar 16, 2020Earnings
- Aerpio Pharmaceuticals, Inc. to Discuss the Results from the TIME-2b Study Conference Call TranscriptMar 18, 2019
- Q4 2018 Aerpio Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2019Earnings
Aadi Bioscience Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 14, 2022 / 06:55PM GMT
Release Date Price:
$12.24
(+1.75%)
Frank Tang;Morgan Stanley;Executive Director
Healthcare Investment Banking,
Great. Good afternoon, everyone. My name is Frank Tang, and welcome to the Morgan Stanley Healthcare Conference. So this is the fireside chat for Aadi Bioscience, and I'm joined on stage by Founder and CEO, Neil Desai; COO, Brendan Delaney; and CFO, Scott Giacobello.
So before we get started, I'd like to read a quick disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Questions & Answers
Frank Tang;Morgan Stanley;Executive Director
Healthcare Investment Banking,
So Neil, to kick things off, it would be great if we could spend a few minutes at the beginning for you to give us an overview of the exciting Aadi story, maybe specifically
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)